Session 2

Oslo Medicines Initiative

A new vision for collaboration between the public and private sectors

Organised by WHO Regional Office for Europe, the Norwegian Ministry of Health and Care Services, and the Norwegian Medicines Agency

Launched at the EHFG last year, the Oslo Medicines Initiative (OMI) aims to build a collaborative platform where stakeholders can come together to identify actions to improve patient-access to effective high cost novel medicines across the European Region.

Continuing dialogue with all stakeholders is paramount to find common ground and agree to transparent, sustainable solutions that are of mutual benefit to Member-States and non-State actors, including health systems, payers, patients, and industry). The initiative aims to reshape the political discourse, implement pragmatic step-by-step solutions, and create partnerships to build a movement for systemic change.

Supported by consultations, background documents and webinars, OMI will culminate in a high-level meeting in Oslo on 13-14 June 2022. OMI is a unique opportunity for stakeholders to discuss some of the major challenges and collectively agree on new opportunities for collaboration. Join us in this session to envision a sustainable future for better access to medicines across Europe and beyond!